Skip to main content
A phase 3 randomized double-blind trial of maintenance with niraparib versus placebo in patients with platinum-sensitive ovarian cancer (ENGOT-OV16/NOVA trial). Matulonis, U., Mahner, S., Wenham, R., Ledermann, J. A., Monk, B. J., Campo, J., Berek, J. S., Vergote, I., Fabbro, M., Katsaros, D., Marth, C., Lorusso, D., Herrstadt, J., Agarwal, S., Martell, R. E., Mirza, M. AMER SOC CLINICAL ONCOLOGY. 2014

View details for Web of Science ID 000358613202163